Article
Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
American journal of human genetics - 1 Dec 2002
Groussin Lionel, Kirschner Lawrence S, Vincent-Dejean Caroline, Perlemoine Karine, Jullian Eric, Delemer Brigitte, Zacharieva Sabina, Pignatelli Duarte, Carney J Aidan, Luton Jean Pierre, Bertagna Xavier, Stratakis Constantine A, Bertherat Jérôme
Abstract excerpt
We studied 11 new kindreds with primary pigmented nodular adrenocortical disease (PPNAD) or Carney complex (CNC) and found that 82% of the kindreds had PRKAR1A gene defects (including seven novel inactivating mutations), most of which led to nonsense mRNA and, thus, were not expressed in patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
